Literature DB >> 9875622

Clinical and genetic studies of spinocerebellar ataxia type 2 in Japanese kindreds.

H Ueyama1, T Kumamoto, S Nagao, S Mita, M Uchino, T Tsuda.   

Abstract

OBJECTIVES: We report the results of clinical and genetic studies from 2 related Japanese kindreds with spinocerebellar ataxia type 2 (SCA2).
MATERIAL AND METHODS: Family A showed 19 patients through 4 generations, while family B showed 6 patients, including dizygotic twin brothers, through 3 generations. We performed clinical, radiological, neurophysiological, and genetic analyses in the family members.
RESULTS: Neurologic analysis of 13 affected patients revealed a mean age at onset of 43.5 years. The most common neurologic finding was cerebellar ataxia with deep sensory disturbance. Slow saccades was found only in the younger patients below age 35 years. Nerve conduction studies revealed subclinical sensory neuropathy. Brain MRI showed the presence of pontocerebellar atrophy. Genetic study using PCR revealed that all affected patients had an expanded CAG allele in the ataxin-2 gene, which led to a final diagnosis of SCA2.
CONCLUSION: SCA2 may be more clinically heterogeneous than previously thought. PCR is useful in differentiating SCA2 from other types of inherited ataxia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9875622     DOI: 10.1111/j.1600-0404.1998.tb07325.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  2 in total

Review 1.  Magnetic resonance imaging biomarkers in patients with progressive ataxia: current status and future direction.

Authors:  Stuart Currie; Marios Hadjivassiliou; Ian J Craven; Iain D Wilkinson; Paul D Griffiths; Nigel Hoggard
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

2.  Peripheral Neuropathy in Spinocerebellar Ataxia Type 1, 2, 3, and 6.

Authors:  Christoph Linnemann; Sophie Tezenas du Montcel; Maryla Rakowicz; Tanja Schmitz-Hübsch; Sandra Szymanski; Jose Berciano; Bart P van de Warrenburg; Karine Pedersen; Chantal Depondt; Rafal Rola; Thomas Klockgether; Antonio García; Gurkan Mutlu; Ludger Schöls
Journal:  Cerebellum       Date:  2016-04       Impact factor: 3.847

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.